CIK: 0001381843 · Show all filings
Period: Q2 2017 (← Previous) (Next →)
Filing Date: Aug 7, 2017
Total Value ($000): $80,196 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| ELV | ANTHEM INC | 55,200 | $10,385 | 12.9% | $160.37 | 0.0% | COM | 036752103 |
| MCK | MCKESSON CORP | 63,100 | $10,382 | 12.9% | $137.75 | +2.8% | COM | 58155Q103 |
| COR | AMERISOURCEBERGEN CORP | 109,700 | $10,370 | 12.9% | $61.79 | +9.5% | COM | 03073E105 |
| CRL | CHARLES RIV LABS INTL INC | 70,212 | $7,102 | 8.9% | $63.72 | +44.5% | COM | 159864107 |
| — | LABORATORY CORP AMER HLDGS | 45,800 | $7,060 | 8.8% | $154.15 | — | COM NEW | 50540R409 |
| GILD | GILEAD SCIENCES INC | 97,600 | $6,908 | 8.6% | $53.11 | -9.0% | COM | 375558103 |
| PFE | PFIZER INC | 204,800 | $6,879 | 8.6% | $21.60 | 0.0% | COM | 717081103 |
| LGND | LIGAND PHARMACEUTICALS INC | 56,200 | $6,823 | 8.5% | $69.95 | 0.0% | COM NEW | 53220K504 |
| BIIB | BIOGEN INC | 25,000 | $6,784 | 8.5% | $264.42 | 0.0% | COM | 09062X103 |
| ANIK | ANIKA THERAPEUTICS INC | 125,000 | $6,168 | 7.7% | $38.78 | +18.7% | COM | 035255108 |
| ICCC | IMMUCELL CORP | 182,133 | $1,335 | 1.7% | $5.34 | +11.1% | COM PAR $0.10 | 452525306 |